Antiviral chemistry & chemotherapy · 1996 · 29 citations · 23 references
Life SciencesMedicinal ChemistryPharmacologyMolecular VirologyStructure-activity RelationshipsVirologyAntiviral AgentsAntiviral PharmacologyEnzyme InhibitionViral ReplicationAntiviral Mechanisms Of ActionAntiviral Natural ProductsAntiviral Structure-activity RelationshipsChemical Structure-activity RelationshipsSyncytium FormationSyncytium InductionViral Replication InhibitionViral Replication Inhibitors
Ingenol 3,5,20-triacetate has recently been identified as a highly potent and selective inhibitor of HIV replication in vitro. To evaluate the potential of ingenol derivatives as anti-HIV agents, several ingenol derivatives have been synthesized and investigated for their anti-HIV activities, structure-activity relationships, and possible mechanisms of action. Among the ingenol derivatives, 13-hydroxyingenol-3-(2,3-dimethylbutanoate)-13-dodecanoate (RD4-2138) proved to be a highly potent and selective inhibitor of HIV replication. Its 50% effective concentration for viral replication in MT-4 cells was 0.07-0.5 nM depending on viral strains, including HIV-2. This concentration was approximately 10 5 -fold lower than its cytotoxic threshold. RD4-2138 was also inhibitory to the syncytium formation induced by cocultivation of Molt-4 cells with Molt-4/III B cells (Molt-4 cells chronically infected with HIV-1). Some correlation was observed with the ingenol derivatives between their inhibitory effects on HTLV-III B replication and surface CD4 expression in MT-4 cells, suggesting that the mechanism of inhibition is in part attributed to the inhibition of virus adsorption through down-regulation of CD4 molecules in the host cells. However, such correlation was not identified between the inhibition of HTLV-IIIB and the activation of protein kinase C. Thus, they might have a potential as effective anti-HIV agents when toxicity in vivo could be elucidated.
23
The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus
Angus Dalgleish, Peter C. L. Beverley, Paul R. Clapham et al. · Nature · 1984 · 3.5K citations
T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV
David Klatzmann, Éric Champagne, S. Chamaret et al. · Nature · 1984 · 2.4K citations